These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14566676)

  • 1. Taxol resistance and its reversal by synthetic isoprenoids in human bladder cancer cell line.
    Nakagawa M; Enokida H; Gotanda T; Tachiwada T; Imazono Y; Kubo H; Nishiyama K; Suzuki S; Inomata K; Kishiye T
    Aktuelle Urol; 2003 Jul; 34(4):250-2. PubMed ID: 14566676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line.
    Enokida H; Gotanda T; Oku S; Imazono Y; Kubo H; Hanada T; Suzuki S; Inomata K; Kishiye T; Tahara Y; Nishiyama K; Nakagawa M
    Jpn J Cancer Res; 2002 Sep; 93(9):1037-46. PubMed ID: 12359058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of multidrug resistance by synthetic isoprenoids in the KB human cancer cell line.
    Nakagawa M; Akiyama S; Yamaguchi T; Shiraishi N; Ogata J; Kuwano M
    Cancer Res; 1986 Sep; 46(9):4453-7. PubMed ID: 3731102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
    Zhu X; Sui M; Fan W
    Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives.
    Hayashi M; Koike K; Rho MC; Kuwano M; Kishiye T; Komiyama K
    Anticancer Drug Des; 2001; 16(4-5):255-60. PubMed ID: 12049484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol.
    Li L; Jiang AC; Dong P; Wang H; Xu W; Xu C
    Ann Surg Oncol; 2009 May; 16(5):1421-8. PubMed ID: 19247716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol).
    Dumontet C; Duran GE; Steger KA; Beketic-Oreskovic L; Sikic BI
    Cancer Res; 1996 Mar; 56(5):1091-7. PubMed ID: 8640766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of combination of taxol and celecoxib on reversing multidrug resistance human breast cancer cells (MCF-7/ Taxol) and explore its underlying mechanism].
    Liu Q; Liu XJ; Chen YJ; Wang J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):326-30, 357. PubMed ID: 21826992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells.
    Thimmaiah KN; Jayashree BS; Germain GS; Houghton PJ; Horton JK
    Oncol Res; 1998; 10(1):29-41. PubMed ID: 9613455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of doxorubicin-resistant human bladder cancer cell line (BUI-87/ADMR) and its mechanism of multidrug resistance.
    Guo H; Lu G; Xiong X; Dong J; Liu S
    Chin Med J (Engl); 1997 Mar; 110(3):167-72. PubMed ID: 9594332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
    Chavanpatil MD; Patil Y; Panyam J
    Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of gamma-glutamylcysteine synthetase and glutathione S-transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistance phenotype.
    Kotoh S; Naito S; Yokomizo A; Kohno K; Kuwano M; Kumazawa J
    J Urol; 1997 Mar; 157(3):1054-8. PubMed ID: 9072542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids.
    Xing H; Wang S; Weng D; Chen G; Yang X; Zhou J; Xu G; Lu Y; Ma D
    Oncol Rep; 2007 Jan; 17(1):117-22. PubMed ID: 17143487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.
    Takeda M; Mizokami A; Mamiya K; Li YQ; Zhang J; Keller ET; Namiki M
    Prostate; 2007 Jun; 67(9):955-67. PubMed ID: 17440963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
    Akiyama S; Yoshimura A; Kikuchi H; Sumizawa T; Kuwano M; Tahara Y
    Mol Pharmacol; 1989 Nov; 36(5):730-5. PubMed ID: 2573823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
    Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
    J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.